Home > Journals > European Journal of Physical and Rehabilitation Medicine > Past Issues > European Journal of Physical and Rehabilitation Medicine 2013 April;49(2) > European Journal of Physical and Rehabilitation Medicine 2013 April;49(2):233-41

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE

A Journal on Physical Medicine and Rehabilitation after Pathological Events


Official Journal of the Italian Society of Physical and Rehabilitation Medicine (SIMFER), European Society of Physical and Rehabilitation Medicine (ESPRM), European Union of Medical Specialists - Physical and Rehabilitation Medicine Section (UEMS-PRM), Mediterranean Forum of Physical and Rehabilitation Medicine (MFPRM), Hellenic Society of Physical and Rehabilitation Medicine (EEFIAP)
In association with International Society of Physical and Rehabilitation Medicine (ISPRM)
Indexed/Abstracted in: CINAHL, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,063


eTOC

 

REVIEWS  UPDATE ON DRUGS IN STROKE REHABILITATION


European Journal of Physical and Rehabilitation Medicine 2013 April;49(2):233-41

language: English

Role, indications, and controversies of antidepressant therapy in chronic stroke patients

Paolucci S.

I.R.C.C.S. Santa Lucia Foundation, Rome, Italy


FULL TEXT  


Antidepressants are a heterogeneous class of drugs that have been developed for the treatment of mood disorders. In the past several years, they have been used in poststroke survivors to treat poststroke depression, central poststroke pain, and poststroke fatigue and as an adjuvant for functional recovery and cognitive function. However, there are still some relevant points to clarify regarding the real role of antdidepressants in stroke patients and further researches are needed to deeply explore their effects on rehabilitation results.

top of page

Publication History

Cite this article as

Corresponding author e-mail

s.paolucci@hsantalucia.it